IRIS
EMDIN, MICHELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 80.749
EU - Europa 43.898
AS - Asia 41.924
SA - Sud America 9.275
Continente sconosciuto - Info sul continente non disponibili 1.217
AF - Africa 1.062
OC - Oceania 83
Totale 178.208
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 76.593
SG - Singapore 15.124
RU - Federazione Russa 10.949
CN - Cina 10.432
IT - Italia 9.794
GB - Regno Unito 8.433
BR - Brasile 7.179
VN - Vietnam 6.014
DE - Germania 3.011
HK - Hong Kong 2.991
CA - Canada 2.878
BD - Bangladesh 2.738
UA - Ucraina 2.667
FR - Francia 1.622
DK - Danimarca 1.587
SE - Svezia 1.416
FI - Finlandia 1.105
IN - India 964
MX - Messico 775
IE - Irlanda 763
AR - Argentina 717
PL - Polonia 710
NL - Olanda 555
TR - Turchia 511
ID - Indonesia 434
IL - Israele 411
EC - Ecuador 385
ZA - Sudafrica 369
ES - Italia 353
JP - Giappone 340
IQ - Iraq 338
PK - Pakistan 298
CO - Colombia 262
VE - Venezuela 205
AT - Austria 203
MA - Marocco 173
UZ - Uzbekistan 159
CL - Cile 152
EU - Europa 149
AE - Emirati Arabi Uniti 138
SA - Arabia Saudita 132
LT - Lituania 130
PY - Paraguay 129
MY - Malesia 110
EG - Egitto 104
PH - Filippine 99
PE - Perù 97
KE - Kenya 91
TN - Tunisia 83
CR - Costa Rica 82
JM - Giamaica 78
KR - Corea 78
UY - Uruguay 71
DZ - Algeria 70
JO - Giordania 68
CH - Svizzera 63
BO - Bolivia 61
BE - Belgio 60
IR - Iran 60
HN - Honduras 59
NP - Nepal 56
SK - Slovacchia (Repubblica Slovacca) 55
AU - Australia 53
AZ - Azerbaigian 49
PT - Portogallo 47
RO - Romania 46
DO - Repubblica Dominicana 42
CZ - Repubblica Ceca 41
AL - Albania 40
GT - Guatemala 40
KZ - Kazakistan 39
NI - Nicaragua 36
TH - Thailandia 36
TW - Taiwan 36
ET - Etiopia 34
TT - Trinidad e Tobago 34
OM - Oman 32
SV - El Salvador 28
HU - Ungheria 27
KG - Kirghizistan 27
GR - Grecia 26
PA - Panama 24
AM - Armenia 23
LB - Libano 23
PS - Palestinian Territory 22
RS - Serbia 22
CI - Costa d'Avorio 21
SN - Senegal 21
GE - Georgia 20
BB - Barbados 19
KW - Kuwait 19
NO - Norvegia 19
NZ - Nuova Zelanda 19
SI - Slovenia 18
LV - Lettonia 17
MD - Moldavia 17
PR - Porto Rico 17
BG - Bulgaria 16
BH - Bahrain 16
QA - Qatar 16
Totale 176.815
Salva come PNG Salva come JPEG
Città #
Dallas 13.958
Singapore 7.661
Southend 5.518
Ashburn 5.226
San Jose 5.043
Beijing 4.105
Woodbridge 2.874
Hong Kong 2.728
Chandler 2.556
Ann Arbor 2.547
Houston 2.387
Los Angeles 2.254
Council Bluffs 2.150
Moscow 1.995
Fairfield 1.914
Chicago 1.877
San Mateo 1.857
Ho Chi Minh City 1.731
Milan 1.625
Falls Church 1.553
Seattle 1.354
Dearborn 1.328
New York 1.253
Jacksonville 1.222
The Dalles 1.186
Wilmington 1.167
Cambridge 1.160
Hanoi 1.087
Rome 1.030
Ottawa 956
Santa Clara 921
Buffalo 907
Hefei 806
Lauterbourg 796
São Paulo 790
Salt Lake City 762
Boardman 760
Dublin 741
Portsmouth 685
Stevenage 685
Pisa 660
Dong Ket 641
Warsaw 640
Helsinki 554
Lawrence 525
Brooklyn 471
Beauharnois 444
Orem 438
Tampa 434
Munich 415
Montréal 406
Montreal 383
London 376
Elk Grove Village 363
Tel Aviv 356
Mexico City 353
Phoenix 343
Florence 303
Frankfurt am Main 299
Tokyo 290
Denver 276
Columbus 271
Chennai 268
Toronto 255
Atlanta 252
Rio de Janeiro 252
Johannesburg 235
Stockholm 235
Istanbul 233
San Diego 230
Amsterdam 227
Poplar 223
Figino 219
Da Nang 210
Nuremberg 203
Haiphong 198
Boston 176
Naples 173
Turin 173
Miami 168
Sterling 165
Redwood City 161
Bologna 159
Lancaster 158
Old Bridge 158
Belo Horizonte 146
San Francisco 144
Tashkent 144
Brasília 139
Manchester 135
Guangzhou 133
Lappeenranta 132
Guayaquil 130
Biên Hòa 123
Washington 122
Ankara 119
Curitiba 119
Mumbai 118
Quito 118
Central District 114
Totale 107.063
Salva come PNG Salva come JPEG
Nome #
Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study 1.851
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 1.707
Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 1.585
Congestion in heart failure: a circulating biomarker-based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology 1.363
Cardiac remodelling - Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 899
High prevalence of wild-type transthyretin cardiac amyloidosis in older adults with carpal tunnel syndrome, heart failure or increased left ventricular mass: The CAPTURE study 739
Left ventricular outflow tract velocity-time integral improves outcome prediction in patients with secondary mitral regurgitation 630
Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study 625
A cross-correlational analysis between electroencephalographic and end-tidal carbon dioxide signals: Methodological issues in the presence of missing data and real data results 517
E-Health in Tuscany Inner Areas: The PROXIMITY-CARE Approach 510
[ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients] 493
Impact of GFR Estimation Formulas on MECKI Score Performance and Prognostic Accuracy in Heart Failure: The MECKI-RENAL Study 487
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 458
[The use of PROMs (patient-reported outcome measures) and PREMs (patient-reported experience measures) in Cardiology: current state and applications to improve patient care] 453
Value of the HFA-PEFF and H2FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 451
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liver disease. 432
[18F]-Florbetaben PET/CT for Differential Diagnosis Among Cardiac Immunoglobulin Light Chain, Transthyretin Amyloidosis, and Mimicking Conditions 420
b-Gamma-glutamyltransferase activity in human vulnerable carotid plaques. 404
Prognostic Significance of Central Apneas Throughout a 24-Hour Period in Patients With Heart Failure 402
A simple echocardiographic score to rule out cardiac amyloidosis 394
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liverdisease. 389
Impaired HDL Cholesterol Function and High Interleukin-1ß Levels Hold Prognostic Value after ST-elevation Myocardial Infarctio 386
Trastuzumab cardiotoxicity and drug cardioprotection in healthy and cardiac dysfunction mouse models 384
Cartella clinica automatizzata per il reparto di cardiologia 378
An Open System for Managing Long Term ECG Recordings 376
Cardiac biomarker testing in the clinical laboratory: Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides 375
A simple echocardiographic score to rule out cardiac amyloidosis 372
Meteorin-like protein is associated with a higher risk profile and predicts a worse outcome in patients with STEMI 369
Intelligent data retrieval system as a decision support in cardiology in an Intranet environment 369
Building medical knowledge from real world registries: The case of heart failure 364
Abnormal T2-STIR magnetic resonance in hypertrophic cardiomyopathy: A marker of advanced disease and electrical myocardial instability 363
"Targeting and Treating Apneas" in "The Breathless Heart: Apneas in Heart Failure" 362
A simple method for measuring baroreflex sensitivity holds prognostic value in heart failure 356
Antithrombotic strategies in the catheterization laboratory for patients with acute coronary syndromes undergoing percutaneous coronary interventions: Insights from the EmploYEd antithrombotic therapies in patients with acute coronary Syndromes HOspitalized in Italian cardiac care units Registry 352
"To Breathe, or Not to Breathe: That Is the Question" in "The Breathless Heart: Apneas in Heart Failure" 350
Central sleep apnea and cardiovascular disease state-of-the-art 348
La neuropatia diabetica 344
A role for gamma-glutamyltransferase in pathogenesis and evolution of cardiovascular diseases. 344
[Central apneas and cardiovascular diseases] 343
Adaptive servo-ventilation therapy does not favourably alter sympatho-vagal balance in sleeping patients with systolic heart failure and central apnoeas: Preliminary data 343
An open computational toolbox to analyze multi- and single-unit sympathetic nerve activity in microneurography 342
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 341
Prognostic Impact of QRS Axis Deviation in Patients Treated with Cardiac Resynchronization Therapy 338
Comparison between BNP values measured in capillary blood samples with a POCT method and those measured in plasma venous samples with an automated platform 337
Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging 337
Abnormal hyperventilation in patients with hepatic cirrhosis: Role of enhanced chemosensitivity to carbon dioxide. 336
Peripheral reflex feedbacks in chronic heart failure: Is it time for a direct treatment? 335
N-terminal fragment of B-type natriuretic peptide predicts coexisting subclinical heart and vessel disease 335
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 335
The Fondazione Toscana Gabriele Monasterio app: a digital health system to improve wellbeing of inpatients with heart or lung disease 334
Etiology, clinical presentation, and management of left main coronary artery aneurysms 334
Myocardial signal intensity decay after gadolinium injection: a fast and effective method for the diagnosis of cardiac amyloidosis 334
Prediction of the chemoreflex gain by common clinical variables in heart failure 334
Markers of fibrosis, inflammation, and remodeling pathways in heart failure 332
Cocaine assumption and transient myocardial edema in asymptomatic cocaine heavy-users 331
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals 329
Treating chemoreflex in heart failure: modulation or demolition? 328
Preliminary usability assessment for a novel robotic interface for remote Doppler-echocardiography 328
Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction 328
Role of tissue characterization by Cardiac Magnetic Resonance in the diagnosis of constrictive pericarditis 325
Arrhythmic risk prediction in non-dilated left ventricular cardiomyopathy: The role of overlap with arrhythmogenic cardiomyopathy 324
Usefulness of late gadolinium enhancement MRI combined with stress imaging in predictive significant coronary stenosis in new-diagnosed left ventricular dysfunction 321
A novel echocardiographic method for estimation of pulmonary artery wedge pressure and pulmonary vascular resistance 321
Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure 320
The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: A multicenter study in Italy. 319
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 319
Adrenergic activation in heart failure: blockade or rebalance? 316
[18F]-florbetaben PET/CT is sensitive for cardiac AL amyloidosis 316
Effects of smoking in patients treated with cardiac resynchronization therapy 314
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals. 313
Arterial thrombo-embolic events in cardiac amyloidosis: a look beyond atrial fibrillation 313
Amyloid deposits and fibrosis on left ventricular endomyocardial biopsy correlate with extracellular volume in cardiac amyloidosis 311
Abnormal ventricular repolarization in hypertensive patients: role of sympatho-vagal imbalance and left ventricular hypertrophy 310
N-terminal prob-type natriuretic peptide is a marker of vascular remodelling and subclinical atherosclerosis in asymptomatic hypertensives 310
Aortic elasticity indices by magnetic resonance predict progression of ascending aorta dilation 310
Clinical and prognostic significance of central and obstructive apnoeas in patients with transthyretin cardiac amyloidosis 309
After the SERVE-HF Trial, Is There Still a Need for Treatment of Central Apnea? 309
Eligibility for vericiguat in a real‐world, contemporary heart failure population 308
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy 308
Biomarcatori di stabilità della placca aterosclerotica (Rassegna) 307
Incremental prognostic value of myocardial fibrosis in patients with non-ischemic cardiomyopathy without congestive heart failure 306
Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study 306
Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure: A Meta-Analysis 306
Sex Profile and Risk Assessment With Cardiopulmonary Exercise Testing in Heart Failure: Propensity Score Matching for Sex Selection Bias 306
Acute right-sided transcutaneous vagus nerve stimulation improves cardio-vagal baroreflex gain in patients with chronic heart failure 305
Using co-creation to develop a cardiology online open course: an effective approach for implementing digital learning 304
Glycosylated haemoglobin is associated with neurohormonal activation and poor outcome in chronic heart failure patients with mild left ventricular systolic dysfunction 304
Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis 304
Amyloid seeding as a disease mechanism and treatment target in transthyretin cardiac amyloidosis 303
CHADS2 and CHA2DS2-VASc scores to predict morbidity and mortality in heart failure patients candidates to cardiac resynchronization therapy 303
Valutazione delle caratteristiche analitiche di un nuovo metodo di dosaggio del BNP 302
An analysis of fMRI signal during voluntary breath hold and carbon dioxide challenge: physiological correction and modeling issues 301
Admission high-sensitivity troponin T and NT-proBNP for outcome prediction in acute heart failure 301
A mechanistic look at sacubitril/valsartan action. Unravelling magician's secrets 301
[Treatment of cardiac fibrosis: from neurohormonal antagonists to CAR-T cells] 300
Influence of preload and afterload on stroke volume response to low-dose dobutamine stress in patients with non-ischemic heart failure: A cardiac MR study 300
[Ten perspectives for research and innovation in cardiac amyloidosis] 299
[Rationale and significance of the Italian Network for Cardiac Amyloidosis] 297
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 297
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 297
Totale 41.080
Salva come PNG Salva come JPEG
Categoria #
all - tutte 888.190
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 888.190
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20228.068 0 1.557 404 889 180 250 922 1.669 502 941 138 616
2022/20235.887 547 376 172 845 776 931 52 486 1.037 118 330 217
2023/20244.142 345 129 800 249 173 445 352 194 212 202 162 879
2024/202534.914 265 325 1.822 648 1.291 1.781 4.145 7.450 2.628 3.835 6.773 3.951
2025/202686.111 4.289 13.588 10.180 10.739 8.513 5.107 8.841 3.759 5.089 5.495 5.099 5.412
2026/20275.138 2.371 2.767 0 0 0 0 0 0 0 0 0 0
Totale 178.208